씨어스
458870KOSDAQ의료용 기기 제조업53.3 / 100
Reference Date: 2026-06-10
Company InformationBased on 2025 Annual Report
Business Overview
Seers Technology provides IoMT platform services using AI algorithms and wearable medical devices, including mobiCARE™ for ECG analysis and thynC™ for inpatient monitoring. mobiCARE™, launched in 2020, is used by over 1,000 medical institutions with 620,000 test cases, while thynC™, launched in 2024, has achieved 12,000 installed beds. Key products include certified wearable medical devices such as ECG monitors and thermometers.
Number of Employees
130people
Average Salary
74.1M KRW
Score Calculation Basis
Detailed Financial Score
3.1x industry avg (risky)
6.6x industry avg (excellent)
In line with industry avg
Avg ▲494.7% (1-year basis)
Avg ▲288.1% (1-year basis)
Avg ROE -3.8% (improving, 2yr)
Detailed News Sentiment
- Positive"씨어스, 올해 영업익 375% 증가 전망… 목표가 7만원"-CGSI증...
CGSI증권의 매수 추천과 목표주가 상향으로 씨어스의 성장 전망이 긍정적으로 평가됨.
- Positive씨어스, 모비케어 UAE 초도물량 출하 임박...FDA·중동 모멘텀 부...
씨어스의 기관투자자 대상 IR 개최로 국내 사업 강화와 글로벌 진출 기대감 증가.
- Positive씨어스 "이달 9일 국내 사업 및 미국·중동 진출 전략 공유…성장 자...
씨어스의 IR을 통해 국내 및 글로벌 전략 공유로 투자자 신뢰 회복 기대.
Detailed Momentum
Near 52w low (5%, downtrend)
1m -34.53% (strong drop)
Volume decreasing
Detailed Disclosure
- Neutral기업설명회(IR)개최2026-06-02
- Neutral분기보고서 (2026.03)2026-05-12
